These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8908288

  • 1. Final report of a randomized controlled study with streptococcal preparation OK-432 as a supplementary immunopotentiator for laryngeal cancer.
    Kimura T, Suzuki K, Motai H, Miyamoto N, Tsuge I, Ito Y, Baba S.
    Acta Otolaryngol Suppl; 1996; 525():135-41. PubMed ID: 8908288
    [Abstract] [Full Text] [Related]

  • 2. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 3. [A study of neoadjuvant chemotherapy in the treatment of cancer of pyriform sinuses].
    Ramos Fernández J, Avilés Mañoso P, Martín Atienza R, Lozano Barriuso MA, Fernández-Vega M.
    Acta Otorrinolaringol Esp; 1994 Sep; 45(6):451-6. PubMed ID: 7873237
    [Abstract] [Full Text] [Related]

  • 4. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 5. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [Abstract] [Full Text] [Related]

  • 6. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.
    Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN.
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):882-7. PubMed ID: 17875854
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
    Watanabe Y, Iwa T.
    J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
    [Abstract] [Full Text] [Related]

  • 8. Role of definitive radiation therapy for larynx preservation in patients with advanced laryngeal cancer.
    Keum KC, Kim GE, Suh CO, Lee JY, Roh JK, Kim KM, Kim YH, Hong WP.
    J Otolaryngol; 1999 Oct; 28(5):245-51. PubMed ID: 10579152
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Oct; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA.
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

  • 15. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H, Yamaguchi Y.
    Cancer; 1997 Jul 01; 80(1):42-9. PubMed ID: 9210707
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study on the effect of adjuvant immunochemotherapy using OK-432 and 5-FU in pharyngeal and laryngeal cancers].
    Yajin K, Harada Y, Tagashira N, Suzuki M, Hirakawa K, Sera K, Nakata M, Takebayashi S, Okazaki H, Yashiki T.
    Gan To Kagaku Ryoho; 1988 Jun 01; 15(6):1921-7. PubMed ID: 3289502
    [Abstract] [Full Text] [Related]

  • 17. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS, Fish B, Fenton JE, Husband DJ.
    Head Neck; 2004 Feb 01; 26(2):127-35. PubMed ID: 14762881
    [Abstract] [Full Text] [Related]

  • 18. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study].
    Yamamura Y, Yasue M, Nakazato H, Ota K.
    Gan To Kagaku Ryoho; 1985 Mar 01; 12(3 Pt 1):541-8. PubMed ID: 3923941
    [Abstract] [Full Text] [Related]

  • 19. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.
    Laryngoscope; 2006 Sep 01; 116(9):1651-6. PubMed ID: 16954998
    [Abstract] [Full Text] [Related]

  • 20. Predictors of local failure in early laryngeal cancer.
    Lohynska R, Slavicek A, Bahanan A, Novakova P.
    Neoplasma; 2005 Sep 01; 52(6):483-8. PubMed ID: 16284693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.